A Korean study published recently suggests that people with type 2 diabetes who are prescribed a particular class of drug ...

Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

Recent research has revealed that the diabetes drug tirzepatide outperforms other medications in both lowering blood sugar ...

Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, suggests ...

slow digestion and speed metabolism—the effect being that people taking the medication tend to eat less and lose weight. Being overweight and obesity are associated with an increased risk of ...

according to a May survey by KFF. Although drugs such as Ozempic originally were developed to treat chronic conditions such ...

semaglutide may promote weight loss and decrease the risk of cancer, diabetes and cardiovascular disease in individuals with obesity or overweight. “Ozempic is a safe medication with a variety ...

A popular weight loss drug reduced the risk of COVID-19 deaths ... and both medicines are also used for the treatment of Type 2 diabetes. People taking the drug still contracted the virus during ...

Weight-loss drugs such as Ozempic come with a risk of severe side effects. The viral weight-loss drug semaglutide, which is available under the commercial names Ozempic and Wegovy, may help slow ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...